Friday, July 12, 2019 2:40:07 PM
Genomic and epigenomic biomarkers are the key to precision medicine.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149763601
____________________________________________________________________________________________
GENETICS INFORMING TRIALS AND PRACTICE:
PHARMACOLOGY + GENOMIC = PHARMACOGENOMICS
The ideal pharmacogenomics test will be able to determine:
• Potential for a medication to be effective – for this person
• The best dose of a medication – for this person
• Avoid risk of serious side effects - for this person
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149157245
- above is cut and pasted from a georgejjl post
Evolution of clinical trials in multiple sclerosis
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148140606
FDA is now testing Real-World Evidence and comparing to randomized controlled trials:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148145719
2018 Conference presentations on pharmacogenomics epidemiology:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148156807
____________________________________________________________________________________________
GENETICS:
CRISPER discovery of likely MOA for 2-73:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144274561
DNA and BIOMARKERS (From Mikesc)
https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-016-0284-4
Apoe4 and Alzheimer's
https://medicalxpress.com/news/2016-08-scientists-reveal-people-apoe4-gene.html
https://www.snpedia.com/index.php/APOE
Anavex 2-73 Won’t Be “Gene Therapy;” Better (from falconer66a)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147087396
Health Conditions Related to Genetic Changes
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147636445
____________________________________________________________________________________________
EPIGENETICS:
Epigenetics and Autoimmune disease:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149317433
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149317468
Anavex sigma-1 receptor agonists may treat epigenetic damage:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147090448
Mitochondrial dysfunction, disease pathology and epigenetics:
https://learn.genetics.utah.edu/content/epigenetics/inheritance/
Epigenetics and Rett Syndrome:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147643763
Epigenetic change:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148594441
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147910951
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147927639
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147906404
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147900786
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142496828
Why SSRI's are a FAIL:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147637039
Fluoride, Epigenetic change and Alzheimer's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147640105
Importance of the COMT gene:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147635325
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147636055
Childhood abuse, the COMT gene and anger:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147637039
____________________________________________________________________________________________
SEX DIFFERENCES:
Men, Women, Alzheimer's and gene expression - (from raja45185)
https://www.asianage.com/life/health/060519/new-drugs-to-target-alzheimers.html
Do women have "younger" brains? (from baltimorebullet)
https://www.mprnews.org/story/2019/02/05/npr-scans-show-womens-brains-remain-youthful-as-male-brains-wind-down
Women and Alzheimers:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934418/
https://www.alz.co.uk/sites/default/files/pdfs/Women-and-Dementia.pdf
Sex hormones and womens' mental health:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148139054
Genetic Mutations & Estrogen Metabolism (COMT)
https://peacewithendo.com/2015/04/genetic-mutations-estrogen-dominance.html
The elegance of the progesterone theory:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147783390
The benefits of HRT, if initiated early enough in healthy women, are far greater than the potential adverse effects.
https://www.mja.com.au/journal/2009/190/6/benefits-oestrogen-following-menopause-why-hormone-replacement-therapy-should-be
More on hormone replacement history:
https://www.forbes.com/sites/forbesbooksauthors/2017/04/16/the-long-and-misunderstood-history-of-hormone-replacement-therapy/#47999b23667c
Progesterone:
https://investorshub.advfn.com/boards/read_msgs.aspx?board_id=11474&NextStart=175189&BatchSize=20
Women and Benzodiazepiens:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145578631
Women and choline:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146528112
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146530875
MS and gender bias
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145789105
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM